AirSculpt Q2 revenue falls more than expected, CFO to retire

Airsculpt Technologies

01/08/2025 11:09

Overview

AirSculpt Q2 revenue declines 13.7%, missing analyst expectations, per LSEG data

Adjusted EBITDA for Q2 beats analyst estimates, indicating operational efficiency

Co announces CFO Dennis Dean's retirement, pending successor appointment

Outlook

Company affirms 2025 revenue guidance of $160 mln to $170 mln

AirSculpt expects 2025 adjusted EBITDA of $16 mln to $18 mln

Company confident in accelerating sales improvement through new offerings

AirSculpt sees growth strategy enhancing comparable sales improvement

Result Drivers

NEW OFFERINGS - Co piloted skin tightening and expanded financing options to attract more customers

DEBT REDUCTION - Co reduced debt by $16 mln, strengthening its balance sheet

LEAD GROWTH - Record growth in leads and increased consultations indicate rising consumer interest

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$44 mln
$45.40 mln (4 Analysts)
Q2 Net Income
-$600,000
Q2 Adjusted EBITDA
Beat
$5.80 mln
$5.33 mln (4 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy."

Wall Street's median 12-month price target for AirSculpt Technologies Inc is $4.75, about 39.2% below its July 31 closing price of $6.61

Press Release: ID:nGNX9b27Xf

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)